β-Blockers in Dialysis Patients: A Nephrocardiology Perspective
Author:
Publisher
American Society of Nephrology (ASN)
Subject
Nephrology,General Medicine
Reference14 articles.
1. Utilization and Costs of Cardiovascular Disease Medications in Dialysis Patients in Medicare Part D
2. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study11The data reported here were supplied by the United States Renal Data System. Interpretation of these data is the responsibility of the authors, and in no way should be seen as an official policy or interpretation of the U.S. government.
3. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada
4. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial
5. Weir MA Dixon SN Fleet JL Roberts MA Hackam DG Oliver MJ Suri RS Quinn RR Ozair S Beyea MM Kitchlu A Garg AX : β-Blocker dialyzability and mortality in older patients receiving hemodialysis [In Press]. J Am Soc Nephrol : 2014
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antihypertensive Medications Use among Chronic Hemodialysis Patients Visiting the Outpatient Department of Nephrology of a Tertiary Care Centre: A Descriptive Cross-sectional Study;Journal of Nepal Medical Association;2023-03-01
2. Sodium First Approach, to Reset Our Mind for Improving Management of Sodium, Water, Volume and Pressure in Hemodialysis Patients, and to Reduce Cardiovascular Burden and Improve Outcomes;Frontiers in Nephrology;2022-07-07
3. Low-Dose Dopamine in the Management of Intradialysis Hypotension: A Retrospective Cohort Study in Nigeria;EMJ Nephrology;2022-06-30
4. Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis;Clinical Medicine Insights: Endocrinology and Diabetes;2022-01
5. Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis;Clinical Kidney Journal;2021-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3